Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1

Gabriele Möller, Bettina Husen, Dorota Kowalik et al. · 2010

Read Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1 by Gabriele Möller, Bettina Husen, Dorota Kowalik et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010969.txt.

Description

Gabriele Möller, Bettina Husen, Dorota Kowalik and co-authors published this enzyme study in PLOS ONE in 2010. Some breast cancers and endometriosis feed on estrogen made locally by an enzyme called 17beta-HSD1, and blocking it is a promising treatment idea. The team tested new blocker candidates built on a hormone scaffold, checking carefully what else they might hit.

They measured the compounds against five related human enzymes and against the target enzyme from marmoset, pig, mouse, and rat, the species used in drug screening. Susceptibility differed profoundly: rodent versions of the enzyme were much less sensitive to the blockers than the human one. Möller and colleagues warn that a candidate can look weak in a mouse and strong in a person, or the reverse, distorting preclinical decisions.

Catalog record

CREATORGabriele Möller, Bettina Husen, Dorota Kowalik et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010969

Browse the full library · About the Tower of Babel